INFLAMMATORY MEDIATORS IN RELATION TO THE DEVELOPMENT OF MULTIPLE ORGAN FAILURE IN PATIENTS AFTER SEVERE BLUNT TRAUMA

被引:185
作者
ROUMEN, RMH
REDL, H
SCHLAG, G
ZILOW, G
SANDTNER, W
KOLLER, W
HENDRIKS, T
GORIS, RJA
机构
[1] LUDWIG BOLTZMANN INST EXPTL & CLIN TRAUMATOL, VIENNA, AUSTRIA
[2] UNIV HEIDELBERG, INST IMMUNOL, W-6900 HEIDELBERG, GERMANY
[3] LORENZ BOHLER HOSP, DEPT ANAESTHESIA & INTENS CARE, VIENNA, AUSTRIA
[4] UNIV INNSBRUCK, DEPT ANAESTHESIA & INTENS CARE MED, A-6020 INNSBRUCK, AUSTRIA
关键词
COMPLEMENT PROTEINS; THROMBOXANE; C-REACTIVE PROTEIN; NEOPTERIN; MULTIPLE TRAUMA; MULTIPLE ORGAN FAILURE; CRITICAL ILLNESS; INFLAMMATION; NEUTROPHILS; ADULT RESPIRATORY DISTRESS SYNDROME;
D O I
10.1097/00003246-199503000-00010
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To evaluate the posttraumatic course of several inflammatory mediators or markers (complement components C3, C3a, terminal complement complex, thromboxane B-2, C-reactive protein, elastase, and neopterin) in relation to the development of multiple organ failure and mortality. Design: Prospective study of a selected patient group. Setting: Surgical intensive care units in three European trauma hospitals. Patients: Patients (n = 56) with severe blunt trauma (Injury Severity Score of greater than or equal to 33). Interventions: Arterial blood samples were sequentially obtained. Measurements and Main Results: Nonsurvivors (n = 8) had significantly higher circulating C3a and elastase concentrations on the first postinjury day, compared with survivors (n = 48). No differences between these groups were found for terminal complement complex, thromboxane B-2, C-reactive protein, and the neopterin/creatinine ratio. Five patients died before day 5. Eighteen patients developed multiple organ failure, which was diagnosed from day 5 onward, leaving 33 patients without multiple organ failure. The patients with subsequent multiple organ failure showed significantly higher mean circulating concentrations of C3a (914 +/- 190 [SEM] ng/mL), terminal complement complex (57 +/- 17 U/ mL), and thromboxane B-2 (275 +/- 37 pg/mL) at the first postinjury day than the patients without multiple organ failure (566 +/- 110 ng/mL, 27 +/- 2 U/mL, and 169 +/- 14 pg/mL, respectively). In patients with multiple organ failure, elastase concentrations were significantly higher on days 2, 3, 4, and 5 postinjury. Neopterin/creatinine ratios, on the other hand, were significantly higher in patients with multiple organ failure when the multiple organ failure had already become established (on days 8 and 10). Conclusion: In multiple trauma patients, excessive triggering of the inflammatory cascade-as expressed by complement activation and stimulation of neutrophils producing elastase-plays an important and early role in the development of multiple organ failure.
引用
收藏
页码:474 / 480
页数:7
相关论文
共 40 条
  • [1] INJURY SEVERITY SCORE - METHOD FOR DESCRIBING PATIENTS WITH MULTIPLE INJURIES AND EVALUATING EMERGENCY CARE
    BAKER, SP
    ONEILL, B
    HADDON, W
    LONG, WB
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1974, 14 (03): : 187 - 196
  • [2] Baue AE, 1990, MULTIPLE ORGAN FAILU
  • [3] EARLY TIME COURSE OF THE ACUTE PHASE PROTEIN RESPONSE IN MAN
    COLLEY, CM
    FLECK, A
    GOODE, AW
    MULLER, BR
    MYERS, MA
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (02) : 203 - 207
  • [4] DEBYDUPONT G, 1987, INTENS CARE MED, V13, P167
  • [5] MULTIPLE ORGAN FAILURE - PATHOPHYSIOLOGY AND POTENTIAL FUTURE THERAPY
    DEITCH, EA
    [J]. ANNALS OF SURGERY, 1992, 216 (02) : 117 - 134
  • [6] FLUID PHASE GENERATION OF TERMINAL COMPLEMENT COMPLEX AS A NOVEL INDEX OF BIOINCOMPATIBILITY
    DEPPISCH, R
    SCHMITT, V
    BOMMER, J
    HANSCH, GM
    RITZ, E
    RAUTERBERG, EW
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (02) : 696 - 706
  • [7] DOMINIONI L, 1980, EUR J SURG RES S1, V33
  • [8] DUSWALD KH, 1985, SURGERY, V98, P892
  • [9] PHOSPHOLIPASE A-2 STIMULATED RELEASE OF PROSTANOIDS FROM THE ISOLATED, PERFUSED RABBIT LIVER - IMPLICATIONS IN REGIONAL CELLULAR INJURY
    FLYNN, JT
    HENRY, JM
    PERKOWSKI, S
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1981, 59 (12) : 1268 - 1273
  • [10] FOSSE E, 1987, ACTA CHIR SCAND, V153, P325